Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
SmartKem To Present At The LD Micro Main Event On October 12th At 11:30 Am PST 2021-10-12 03:17
CLSA:Fosun's Outstanding Performance on ESG, Solidifying Leadership in Sustainable Development 2021-10-08 13:42
Resonant Inc. Expands Strategic Partnership with Murata Manufacturing Co., Ltd., the World's Leading RF Module and Filter Provider 2021-10-07 11:09
Sasol announces lead role in feasibility study for the Boegoebaai Green Hydrogen Project 2021-10-07 03:11
NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap Conference 2021-10-05 18:45
/DISREGARD RELEASE: Infineon Technologies AG/ 2021-10-05 16:10
Infineon launches SLS37 V2X Hardware Security Module to safeguard vehicle to everything communication 2021-10-04 11:03
BioVaxys Begins Toxicity Study Ahead of CoviDTH IND Submission 2021-09-28 20:00
BioVaxys Prepares for Groundbreaking Study on reduced ACE2 binding capabilities of Hapten-modified SARS-CoV-2 proteins 2021-09-23 15:00
Sasol commits to net zero ambition by 2050, triples 2030 GHG emission reduction targets 2021-09-22 22:07
Arçelik joins the UN Global Compact CFO Taskforce to align finance and sustainability for real world change 2021-09-22 18:48
Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug 2021-09-22 18:45
BioVaxys Cancer Vaccine Manufacturing Partner Bio Elpida Reaches Bioproduction Milestone 2021-09-17 15:00
Sasol, Haldor Topsøe expand G2LTM licensing collaboration to grow sustainable synthetic fuels and chemicals globally 2021-09-15 20:23
10,000 green hydrogen generators per month: groundbreaking for Enapter electrolyser mass production in North Rhine-Westphalia 2021-09-15 04:25
BioVaxys Bioproduction Partner WuXi Biologics Completes Synthesis Of Recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH Programs 2021-09-14 15:00
RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval 2021-09-13 19:00
Sasol and Central Energy Fund sign strategic MOU to accelerate gas development in South Africa 2021-09-07 20:58
Further Study in humans shows that the DTH response, the basis for CoviDTH, is highly durable and persists for at least one year after COVID-19 exposure or vaccine administration 2021-09-07 20:00
NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease 2021-09-07 12:00
1 24 25 26 27 28 63